Dog Owner Dashboard

CBD

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside.

Summary:

A review of studies evaluating cannabinoids for neuropathic pain management in the clinical and preclinical literature.

Conclusion:

“The present review suggests that cannabinoids show promise for treatment of neuropathic pain in humans either alone or as an add-on to other therapeutic agents. Further evaluation of safety profiles associated with long term effects of cannabinoids are, therefore, warranted.”

Author & Journal:Rahn, EJ, et al, Neurotherapeutics, 2009
Learn More

Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain

Summary:

“Unless the nation develops an increased tolerance to chronic pain, reduction in opioid prescribing leaves a vacuum that will be filled with other therapies.” Consideration for the pharmacological, social and legal role of cannabis as an alternative for prescribing opioids.

Conclusion:

The prescribing of opioid therapy for chronic noncancer pain advanced unchecked until opioid-related adverse events and other consequences reached epic proportions. To ensure the medical community does not repeat this mistake with cannabis, physicians should balance the need to keep pace with the swiftly evolving cultural, social, and legal climate surrounding cannabis use for pain with the imperative to guide practice with sound science.

Author & Journal:Choo, Esther K. et al, JAMA, 2016
Learn More

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs

Summary:

“The objectives of this study were to determine basic oral pharmacokinetics, and assess safety and analgesic efficacy of a cannabidiol (CBD) based oil in dogs with osteoarthritis (OA).”

Conclusion:

“Pharmacokinetics revealed an elimination half-life of 4.2 h at both doses and no observable side effects. Clinically, canine brief pain inventory and Hudson activity scores showed a significant decrease in pain and increase in activity (p < 0.01) with CBD oil. Veterinary assessment showed decreased pain during CBD treatment (p < 0.02). No side effects were reported by owners, however, serum chemistry showed an increase in alkaline phosphatase during CBD treatment (p < 0.01).”

Author & Journal:Gamble, Lauri-Jo et al, Frontiers in Veterinary Science, 2018
Learn More